Carrie J. Finno, PhD DACVIM: No financial relationships to disclose
Presentation Description / Summary: This case-based discussion will focus on recently available genetic disease tests specific to foals and yearlings in the United States, including the five-panel genetic test in the American Quarter Horse and Paint Horse that now includes myosin-heavy chain myopathy as an additional option; lavender foal syndrome, cerebellar abiotrophy, and occipitoatlantoaxial malformation in Arabian Horses; dwarfism and hydrocephalus in Friesians; hoof wall separation disease in Connemara ponies; Warmblood fragile foal syndrome in Warmblood and Thoroughbred foals; and equine inherited familial hyperparathyroidism in Thoroughbreds. A discussion of how to determine if a genetic test is scientifically valid will also be included.
Learner Outcomes: (1) Identify when genetic testing should be included in a diagnostic work-up for various conditions (2) Learn how to determine if a “new” genetic test is scientifically valid or not
Learning Objectives:
Upon completion, participants will be able to identify when genetic testing should be included in a diagnostic work-up for various conditions.
Upon completion, participants will be able to determine if a “new” genetic test is scientifically valid or not.
Upon completion, participants will be able to recognize new genetic diseases in the horse.
